Measure would start stem cell research center at KU Med

Posted: Published on February 28th, 2013

This post was added by Dr. Richardson

Topeka A bill pushed by abortion opponents that would require the Kansas University Medical Center to establish a center that focuses on adult stem cell research will be debated in the Senate on Thursday.

Senate Bill 199, which would create the Midwest Stem Cell Therapy Center, was authored by 22 conservative Republican senators, including Senate President Susan Wagle of Wichita, Majority Leader Terry Bruce of Hutchinson, and Public Health and Welfare Chairwoman Mary Pilcher-Cook of Shawnee.

"This has the potential of putting Kansas on the map in making actual patient therapies available," Pilcher-Cook said.

Gov. Sam Brownback also expressed support for the concept.

"Having an adult stem cell center is not only highly plausible, it's being done and used in many places around the world," he said.

"If Kansas could take a leadership position in that, it could be a highly useful thing for people to get treatments. There are number of different maladies now being treated by non-controversial stem cell treatments," he said. He added, "Let's see what develops in the process and in the bill."

The bill would prohibit the center from using embryonic stem cells or cells taken from aborted fetal tissue. Abortion opponents oppose human embryonic stem cell research because it involves the destruction of the embryo.

Under the proposal, KU would appoint a director of the center who would be responsible for oversight of patient treatment and research with adult, cord blood and other non-embryonic stem cells.

The director could solicit grants, gifts and contributions. The bill also sets up a 13-member advisory board.

The center would require $1.1 million to renovate a lab and hire staff and $750,000 annually after that. But the funding has not been secured.

Read the original:
Measure would start stem cell research center at KU Med

This entry was posted in Uncategorized. Bookmark the permalink.

Comments are closed.